MLM is investigating complementary technologies that will further improve chronic wound management.  These promising advancements are in various stages of development.  Here's what's happening behind the scenes:

- Addition of autologous growth factors
- Negative pressure wound therapy
- Anti-microbial/biotic drugs
- Soft tissue repair/augmentation
- Bio-active matrices to treat inflammatory and infectious wounds
- Hard tissue repair for fracture, bone void filler, osteotomies and fusions
- Biologic barrier membranes for covering superficial wounds
- Adhesion barriers 


MLM is also expanding its product line to include veterinarian applications.  Stay tuned for details.